NSE › Healthcare

Hester Biosciences Limited (HESTERBIO)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,442.40+3.17%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹100 cr

Revenue YoY

+22.2%

Net profit

₹16 cr

Profit YoY

+1138.0%

EPS

₹9.09

EPS estimate

₹12.65

Net margin

16.0%

EPS came in at 9.09 against a street estimate of 12.65 — a miss of 28.1%.

Key statistics

Market cap

₹2,108 cr

P/E

15.4

Forward P/E

0.0

P/B

5.85

Book value

₹423.46

EPS (TTM)

₹158.82

52-week high

₹2,683.60

52-week low

₹1,233.94

50-day MA

₹2,188.57

200-day MA

₹1,719.82

Beta

0.49

Shareholding

Promoters

68.79%

Institutions

0.27%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hester Biosciences Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.